Robbins Farley’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.86M | Buy |
+26,567
| New | +$1.86M | 0.86% | 45 |
|
|
2023
Q4 | – | Sell |
-400
| Closed | -$27.1K | – | 177 |
|
|
2023
Q3 | $27.1K | Hold |
400
| – | – | 0.02% | 94 |
|
|
2023
Q2 | $28.6K | Hold |
400
| – | – | 0.02% | 84 |
|
|
2023
Q1 | $27.8K | Hold |
400
| – | – | 0.02% | 87 |
|
|
2022
Q4 | $27.1K | Hold |
400
| – | – | 0.02% | 82 |
|
|
2022
Q3 | $22K | Hold |
400
| – | – | 0.02% | 78 |
|
|
2022
Q2 | $26K | Buy |
+400
| New | +$26K | 0.03% | 58 |
|
|
2022
Q1 | – | Sell |
-400
| Closed | -$23K | – | 132 |
|
|
2021
Q4 | $23K | Hold |
400
| – | – | 0.02% | 69 |
|
|
2021
Q3 | $24K | Hold |
400
| – | – | 0.02% | 77 |
|
|
2021
Q2 | $24K | Hold |
400
| – | – | 0.03% | 47 |
|
|
2021
Q1 | $22K | Buy |
+400
| New | +$22K | 0.02% | 78 |
|